Efficacy and Safety Study of a Test Naproxen Sodium 220mg Tablet in Postoperative Dental Pain
Status:
Completed
Trial end date:
2019-04-15
Target enrollment:
Participant gender:
Summary
To evaluate analgesic onset, efficacy, and safety of a single dose of 440 mg of naproxen
sodium administered as two Test Naproxen Sodium 220 mg tablets compared with two commercial
naproxen sodium products (two naproxen sodium 220 mg tablets and two naproxen sodium 220 mg
liquid gels capsules) and placebo in the dental pain model following third-molar extractions.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division